API（Active Pharmaceutical Ingredient）：是用于药品制造中的任何一种物质或物质的混合物，且在制药中，成为药品的一种活性成分。该物质在疾病的诊断、治疗、症状缓解、处理或疾病的预防中有药理活性或其他直接作用，或者能影响机体的功能或结构。GenScript提供的常用原料药多肽相关产品如下：
| 产品编号 | 英文名 | 中文名 | CAS号 | 序列 | 研究领域 | 订购 |
|---|---|---|---|---|---|---|
| RP60001 | Liraglutide | 利拉鲁肽 | 204656-20-2 | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
二型糖尿病 | 询价 |
| RP60002 | Dulaglutide | 度拉鲁肽/杜拉鲁肽 | 879600-73-4 |
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Gly-Gly |
二型糖尿病 | 询价 |
| RP60003 | Semeglutide | 索玛鲁肽 | 910463-68-2 |
H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-N6-[N-(17-carboxy-1-oxoheptadecyl-L-γ-glutamyl[2-(2-aminoethoxy)ethoxy]acetyl[2-(2-aminoethoxy) ethoxy]acetyl]-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
二型糖尿病 | 询价 |
| RP60004 | Leuprolide | 亮丙瑞林 | 74381-53-6 | Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt acetate |
子宫内膜异位症；子宫肌瘤；绝经前乳腺癌；前列腺癌等。 | 询价 |
| RP60005 | Octreotide | 奥曲肽 | 79517-01-4 | D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol) |
肢端肥大症 | 询价 |
| RP60006 | Lanreotide | 兰瑞肽 | 108736-35-2 | H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bond) |
肢端肥大症 | 询价 |
| RP60007 | Glatiramer acetate | 醋酸格拉替雷 | 147245-92-9 | (Glu,Ala,Lys,Tyr)x.XCH3COOH |
多发性硬化症 | 询价 |
| RP60008 | Teriparatide Acetate | 醋酸特立帕肽 | 52232-67-4 (net), 99294-94-7 (hydrate) | H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH |
绝经后骨质疏松症 | 询价 |
| RP60009 | Bortezomib | 硼替佐米 | 179324-69-7 | N-(2- pyrazine carbonyl)-Phe-Leu boric acid |
多发性骨髓瘤 | 询价 |
| RP60010 | Carfilzomib | 卡非佐米 | 868540-17-4 | (2S)-N-((S)-1-((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-ylcarbamoyl)-2-phenylethyl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)-4-methylpentanamide |
多发性骨髓瘤 | 询价 |
更多原料药类多肽相关产品，请致电400-025-8686转5811/5859或发送邮件至peptide@nrapc.com进行垂询。
中间体是原料药工艺步骤中产生的、必须经过进一步分子变化或精制才能成为原料药的一种物料。中间体可以分离或不分离。
| 产品编号 | 英文名 | 中文名 | CAS号 | 序列 | 订购 |
|---|---|---|---|---|---|
| RP60011 | N-Acetyl-Phe-Octreotide | N-乙酰基-苯丙氨酸-奥曲肽 | 173606-11-6 | D-phe-L-cys-L-phe-D-try-N6-acetyl-L-lys-L-thr-N-[(1R, 2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-Cysteinamide cyclic (2→7)-disulfide |
询价 |
| RP60012 | ([ring-D5]Phe3)-Octreotide | / | 1134880-79-7 | H-D-Phe-Cys-[ring-D5]Phe-D-Trp-Lys-Thr-Cys-L-threoninol(Disulfide bond) |
询价 |
| RP60013 | [Nal3]Octreotide acetate | / | 848820-27-9 | H-D-Phe-Cys-1-Nal-D-Trp-Lys-Thr-Cys-Thr-ol, cyclic disulfide |
询价 |
| RP60014 | [Tyr3,Lys5(Boc)]octreotide acetate | / | 147790-89-4 | H-D-Phe-Cys-Tyr-D-Trp-Lys(Boc)-Thr-Cys-Thr-ol, cyclic disulfide |
询价 |
| RP60015 | TETA-Octreotide acetate | / | 226084-96-4 | TETA-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide |
询价 |
| RP60016 | Human GLP-1 (7-37) | 人胰高血糖素样肽-1 (7-37) | 106612-94-6 | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH |
询价 |
| RP60017 | Glucagon-like peptide 1 (1-37) | 胰高血糖素样肽-1 (1-37) | 87805-34-3 | H-His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly-OH |
询价 |
| RP60018 | Acetylcysteine Ph. Eur. | N-乙酰-L-半胱氨酸 | 616-91-1 | N-Acetyl-L-cysteine |
询价 |
| RP60019 | GsMTx4 | / | 1209500-46-8 | H-Gly-Cys-Leu-Glu-Phe-Trp-Trp-Lys-Cys-Asn-Pro-Asn-Asp-Asp-Lys-Cys-Cys-Arg-Pro-Lys-Leu-Lys-Cys-Ser-Lys-Leu-Phe-Lys-Leu-Cys-Asn-Phe-Ser-Phe-NH2 |
询价 |
| RP60020 | LY-2510924 | / | 1088715-84-7 | Cyclo[Phe-Tyr-Lys(iPr)-D-Arg-2-Nal-Gly-D-Glu]-Lys(iPr)-NH2 |
询价 |
更多中间体多肽相关产品，请致电400-025-8686转5811/5859或发送邮件至peptide@nrapc.com进行垂询。
杂质主要是在生产过程中带入的起始原料、中间体、聚合体、副反应产物，以及贮藏过程中的降解产物等。
| 产品编号 | 英文名 | 中文名 | CAS号 | 分子式 | 订购 |
|---|---|---|---|---|---|
| RP60021 | Liraglutide Impurity 22 TFA Salt | 利拉鲁肽杂质22三氟乙酸盐 | 536721-25-2 | C25H47NO5 | 询价 |
| RP60022 | Leuprolide Acetate EP Impurity D | 醋酸亮丙瑞林EP杂质D | 1926163-25-8 | C61H86N16O13 | 询价 |
| RP60023 | Leuprolide Acetate EP Impurity H | 醋酸亮丙瑞林EP杂质H | 112710-58-4 | C59H84N16O12 | 询价 |
| RP60024 | N-Acetyl-Phe-Octreotide | 奥曲肽杂质1 | 83795-61-3 | C51H68N10O11S2 | 询价 |
| RP60025 | FR 179642 | 米卡芬净杂质 | 168110-44-9 | C35H52N8O20S | 询价 |
| RP60026 | FR 901379 | 米卡芬净杂质 | 144371-88-0 | C51H82N8O21S | 询价 |
| RP60027 | Bortezomib Impurity 2 | 硼替佐米杂质2 | 114457-94-2 | C14H13N3O3 | 询价 |
| RP60028 | Bortezomib Impurity 4 | 硼替佐米杂质4 | 289472-81-7 | C19H24N4O3 | 询价 |
| RP60029 | Bortezomib Impurity 5 | 硼替佐米杂质5 | 1132709-16-0 | C19H25BN4O4 | 询价 |
| RP60030 | Bortezomib Impurity 21 | 硼替佐米杂质21 | 18680-27-8 | C10H18O2 | 询价 |
更多杂质多肽相关产品，请致电400-025-8686转5811/5859或发送邮件至peptide@nrapc.com进行垂询。
